Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications

by Moses Fung, Yan Yuan, Harold Atkins, Qian Shi, Tania Bubela
Published 2017-05-01

Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis

by Komal Adeel, Nathan J. Fergusson, Risa Shorr, Harold Atkins, Kevin A. Hay
Published 2021-01-01

The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experience

by Amarilis Figueiredo, Rabih Kassis, Rashed Albacker, Arleigh McCurdy, Natasha Kekre, Harold Atkins
Published 2019-10-01

Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase...

by Justin Presseau, Kednapa Thavorn, Joshua Montroy, Natasha Kekre, Gisell Castillo, Sarah Asad, Madison Foster, Terry Hawrysh, Harold Atkins, Stuart Schwartz, Robert A Holt, Raewyn Broady
Published 2021-03-01

Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study

by Gisell Castillo, Manoj Lalu, Sarah Asad, Madison Foster, Natasha Kekre, Dean Fergusson, Terry Hawrysh, Harold Atkins, Kednapa Thavorn, Joshua Montroy, Stuart Schwartz, Robert Holt, Raewyn Broady, Justin Presseau, on behalf of the GO CART team
Published 2021-03-01

Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials

by Madison Foster, Dean A Fergusson, Terry Hawrysh, Justin Presseau, Natasha Kekre, Stuart Schwartz, Gisell Castillo, Sarah Asad, Grace Fox, Harold Atkins, Kednapa Thavorn, Joshua Montroy, Robert A Holt, Zarah Monfaredi, Manoj M Lalu
Published 2020-10-01